Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.68 |
| ▸ | RAB9A | P51151 | 5/20 | 0.68 |
| ▸ | GAA | P10253 | 4/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156005 | 0.87 | CA1 (0.58) | TDP1MAPK1ALDH1A1HSD17B10TSHR | |
| SCHEMBL39057 | 0.82 | MAPT (1.00) | MAPTRAB9AGAATDP1MAPK1 | |
| SCHEMBL1459772 | 0.82 | MAPT (1.00) | MAPTRAB9AGAATDP1MAPK1 | |
| SCHEMBL10311786 | 0.80 | NPC1 (0.68) | MAPTRAB9AGAATDP1MAPK1 | |
| SCHEMBL14104855 | 0.80 | MAPT (0.68) | MAPTRAB9AGAATDP1MAPK1 | |
| SCHEMBL9218582 | 0.79 | KMT2A (0.54) | MAPTTDP1MAPK1L3MBTL1KDM4E | |
| SCHEMBL22783761 | 0.78 | S100B (0.68) | MAPTRAB9AGAATDP1MAPK1 | |
| SCHEMBL10311785 | 0.78 | RAB9A (0.78) | MAPTRAB9AGAANPC1KDM4E | |
| SCHEMBL8044644 | 0.77 | RAB9A (0.63) | MAPTRAB9AGAATDP1MAPK1 | |
| SCHEMBL28233594 | 0.77 | MAPT (0.63) | MAPTRAB9AGAATDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0403797-B1 | The use of a light stabilizer comprising an aryl nitrogen compound for stabilizing an organic dye | TAIYO YUDEN KK (JP) | 1995-11-22 | — | — | EP | claimed |
| EP-0403797-A2 | The use of a light stabilizer comprising an aryl nitrogen compound for stabilizing an organic dye | TAIYO YUDEN CO., LTD. (JP) | 1990-12-27 | — | — | EP | claimed |
| US-20110046378-A1 | Novel Imaging Agents for Detecting Neurological Dysfunction | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2011-02-24 | — | — | US | disclosed |
| EP-0403797-B1 | The use of a light stabilizer comprising an aryl nitrogen compound for stabilizing an organic dye | TAIYO YUDEN KK (JP) | 1995-11-22 | — | — | EP | disclosed |
| US-5318882-A | Nitrosodiphenylamine compounds render dyes lightfast | TAIYO YUDEN CO., LTD. (JP) | 1994-06-07 | — | — | US | disclosed |
| EP-0403797-A2 | The use of a light stabilizer comprising an aryl nitrogen compound for stabilizing an organic dye | TAIYO YUDEN CO., LTD. (JP) | 1990-12-27 | — | — | EP | disclosed |
| US-4304939-A | Preparation of N-phenyl-N-alkylphenylenediamines | UOP INC. (US) | 1981-12-08 | — | — | US | disclosed |
| US-4163015-A | ANTIBACTERIAL AGENTS | STERLING DRUG INC. (US) | 1979-07-31 | — | — | US | disclosed |
| US-4138405-A | BACTERICIDES | STERLING DRUG INC. (US) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046378-A1 | Novel Imaging Agents for Detecting Neurological Dysfunction | FABP7, SLC18A3, TSPO | MAPT 35/4885RAB9A 1606/4885GAA 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.